Screening CT angiography in patients with suspected fibromuscular dysplasia: improved patient care with single-session skull vertex to pelvis coverage.
Computed tomography angiography (CTA)
fibromuscular dysplasia (FMD)
screening
Journal
Cardiovascular diagnosis and therapy
ISSN: 2223-3652
Titre abrégé: Cardiovasc Diagn Ther
Pays: China
ID NLM: 101601613
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
19
5
2020
Statut:
ppublish
Résumé
Imaging plays a key role in the workup of patients with clinically suspected fibromuscular dysplasia (FMD), and research has highlighted the potential of computed tomography angiography (CTA) in screening for thoracic, abdominal, and pelvic arterial abnormalities in these patients. We sought to evaluate imaging findings from patients with suspected or diagnosed FMD who underwent screening CTA at our institution with a novel single-acquisition protocol that offers increased anatomic coverage, with images obtained from the skull vertex to the pelvis. Images from 80 consecutive patients scanned with the novel single-session CTA protocol covering the skull vertex to the pelvis were compared with images from 20 additional consecutive patients who underwent CTA for the head and neck separate from CTA of the chest, abdomen, and pelvis. Compared with CTA performed in separate sessions, the single-session CTA protocol decreased the radiation dose by 38% (P<0.001) and decreased the contrast dose by 39% (P<0.001), with satisfactory image quality noted in all instances. Additionally, higher mean contrast attenuation was noted in the aortic arch with use of the novel protocol (409±76 HU) versus with use of the dual-acquisition protocol (260±38 HU; P<0.001). These results suggest that use of a novel single-session CTA protocol extending from the skull vertex to the pelvis provides effective screening imaging in patients with suspected or diagnosed FMD as compared with multisession, standard-pitch CTA.
Sections du résumé
BACKGROUND
BACKGROUND
Imaging plays a key role in the workup of patients with clinically suspected fibromuscular dysplasia (FMD), and research has highlighted the potential of computed tomography angiography (CTA) in screening for thoracic, abdominal, and pelvic arterial abnormalities in these patients. We sought to evaluate imaging findings from patients with suspected or diagnosed FMD who underwent screening CTA at our institution with a novel single-acquisition protocol that offers increased anatomic coverage, with images obtained from the skull vertex to the pelvis.
METHODS
METHODS
Images from 80 consecutive patients scanned with the novel single-session CTA protocol covering the skull vertex to the pelvis were compared with images from 20 additional consecutive patients who underwent CTA for the head and neck separate from CTA of the chest, abdomen, and pelvis.
RESULTS
RESULTS
Compared with CTA performed in separate sessions, the single-session CTA protocol decreased the radiation dose by 38% (P<0.001) and decreased the contrast dose by 39% (P<0.001), with satisfactory image quality noted in all instances. Additionally, higher mean contrast attenuation was noted in the aortic arch with use of the novel protocol (409±76 HU) versus with use of the dual-acquisition protocol (260±38 HU; P<0.001).
CONCLUSIONS
CONCLUSIONS
These results suggest that use of a novel single-session CTA protocol extending from the skull vertex to the pelvis provides effective screening imaging in patients with suspected or diagnosed FMD as compared with multisession, standard-pitch CTA.
Identifiants
pubmed: 32420100
doi: 10.21037/cdt.2020.02.06
pii: cdt-10-02-201
pmc: PMC7225442
doi:
Types de publication
Journal Article
Langues
eng
Pagination
201-207Informations de copyright
2020 Cardiovascular Diagnosis and Therapy. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/cdt.2020.02.06). The authors have no conflicts of interest to declare.
Références
Int J Cardiol. 2016 Oct 15;221:970-6
pubmed: 27441477
Int J Stroke. 2010 Aug;5(4):296-305
pubmed: 20636713
Vasc Med. 2019 Apr;24(2):164-189
pubmed: 30648921
Radiol Clin North Am. 2010 Jan;48(1):9-29
pubmed: 19995627
Radiol Clin North Am. 2009 Jan;47(1):27-40
pubmed: 19195532
Br J Radiol. 2017 Apr;90(1072):20160567
pubmed: 28055253
Imaging Med. 2009 Oct;1(1):65-84
pubmed: 22308169
Orphanet J Rare Dis. 2007 Jun 07;2:28
pubmed: 17555581
Circulation. 2014 Mar 4;129(9):1048-78
pubmed: 24548843
Circulation. 2012 Jun 26;125(25):3182-90
pubmed: 22615343
JACC Cardiovasc Imaging. 2017 May;10(5):554-561
pubmed: 27665159